ABSTRACT OBJECTIVE This study describes the etiology of community-acquired pneumonia (CAP) in hospitalized adult patients in New Caledonia, a French archipelago in the South Pacific.
Introduction
Community-acquired pneumonia (CAP) is an important cause of hospitalization and death worldwide (Garau & Calbo 2008) . Antimicrobial treatment must be prompt but is often given in the absence of, or before, microbiological investigations, based on specific guidelines adapted to local microbial patterns (Woodhead et al. 2005; Macfarlane & Boldy 2004; Mandell et al. 2007 ).
New Caledonia is a French archipelago in the South Pacific. Its population is approximately 230,800 people (2004 census) divided in different ethnic groups: Melanesians (44%), Europeans (34%), Wallisians (9%), Tahitians (2.6%), Indonesians (2.5%) and others (7.9%).
The climate is tropical and oceanic with two marked seasons: a warm and wet season from December to March and a cooler one from June to September. Patients with respiratory infections are usually referred to the Territory Hospital in Noumea hosting intensive care unit facilities and specialist chest physicians. Everyone have access to the health care system.
There has been no comprehensive study of the etiology of CAP in New Caledonia; diseases management is based on French guidelines (AFSSAPS 2005) . However, locally-developed treatment guidelines have been effective in some countries of the Pacific region (Elliott et al. 2005) . Moreover, specific etiologies have been reported in New Caledonia (Burkholderia pseudomallei, Histoplasma capsulatum) which could be taken into account to establish treatment guidelines (Estivals et al. 2008; Noel et al. 1995) .
We conducted a prospective study over a one year period in adult patients hospitalized in New Caledonia main hospital to (i) determine the etiology of CAP, (ii) evaluate the performances of locally available laboratory tests and (iii) assess the vaccination preventable proportion of causative agents, with a special focus on Streptococcus pneumoniae and influenza.
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Methods
Study design
Adult patients, aged 16 years or older, admitted to the Territory Hospital with suspected CAP (n = 173) were evaluated prospectively between December 2006 and November 2007. We used the following criteria for confirmation of CAP: presence of lower respiratory tract infection symptoms at initial presentation or within 48 hours of being hospitalized associated with infiltrates on chest X-ray. Patients with HIV related immunosuppression, tuberculosis or any other illness causing radiographic abnormalities (lung cancer, for example) were excluded. Eligibility was confirmed for each patient by a senior chest physician. Patients lacking respiratory specimens for microbiological investigations were also excluded.
Ethics, patient evaluation, data and sample collection
The New Caledonian Health Authorities approved the study protocol and informed consent was obtained from all patients. Patient data were collected using a standardized questionnaire, including pneumococcal and influenza immunization history. Chest X-ray patterns and laboratory results at presentation and during the hospital stay were collected. The two criteria used to assess CAP severity were admission to the intensive care unit (ICU) and the pneumonia severity index (PSI), defining severe disease as risk classes IV and V (Fine et al. 1997 ).
Respiratory tract specimens (sputum, tracheobronchial aspirate -TBA -, bronchoalveolar lavage -BAL -or protected specimen brush -PSB -), two blood cultures and, when indicated pleural fluid, were collected shortly after admission, before starting antibiotherapy.
We additionally took paired sera for serology, urine for antigen testing, and nasopharyngeal swabs for virus detection.
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Microbiological laboratory tests
Microbiological tests were carried out on respiratory specimens according to the French Society of Microbiology (SFM) criteria (SFM 2007) . Sputum samples were Gram stained and leukocytes and epithelial cells counts recorded per X100 microscopic field. Only good quality specimens (>25 granulocytes and <10 epithelial cells) were retained for analysis (Murray & Washington 1975) . Sputum, TBA, BAL, PSB and pleural fluid samples were cultured at 37°C on blood agar with nalidixic acid, chocolate agar and Sabouraud agar (when positive for yeast on Gram stain). Cultures were counted, with results expressed as colony-forming units per millilitre (CFU/mL) and interpreted using the SFM standards.
Blood cultures were analyzed with the BacT/ALERT ® 3D system (bioMérieux, France).
Influenza viruses A and B, parainfluenza virus-3 (PIV-3) and adenovirus (ADV) were 
PCR assay
RNA and DNA from sputum, TBA, BAL or PSB samples were extracted using a single format magnetic silica-based method automated on the EasyMag system (bioMérieux, France).
A molecular assay was used for parallel detection of Chlamydophila pneumoniae, Mycoplasma pneumoniae and Legionella spp. Real-time PCR was performed using the LightCycler ® 2.0 (Roche Diagnostics, New Zealand) with primers and hybridization probes, pasteur-00705151, version 1 -7 Jun 2012
as described elsewhere (Raggam et al. 2005) . Influenza viruses A and B were detected from respiratory samples by real-time RT-PCR. We used primers and hybridization probes previously described for influenza B virus (Smith et al. 2003) . Influenza A virus-specific hybridization probes were used, allowing H1N1 and H3N2 subtypes dicrimination by melting temperature analysis (Stone et al. 2004) .
Serology
Paired sera samples were collected when possible at an optimal interval of three weeks.
Antibodies to influenza A and B viruses, ADV, RSV, PIV types 1, 2, and 3 (Virion Institute, Switzerland) were detected by complement-fixation tests. M. pneumoniae IgM antibodies were tested by indirect ELISA (RIDASCREEN ® , r-biopharm, Germany).
Diagnostic criteria for determination of microbial etiology
Etiology was classified as 'definite', 'probable' or 'unknown' following SFM guidelines and published criteria (SFM 2007; Ruiz et al. 1999) . It was considered definite when (1) a usual 
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The etiology of pneumonia was classified as probable when a valid sputum sample yielded one or two predominant bacterial strains.
Statistics
Stata SE 8.0 (StataCorp, Texas, USA) was used for all calculation. Continuous variables were compared using the Student's t test when the theoretical numbers were low. Categorical variables were compared by using the χ 2 test or Fisher's exact test. Poisson regression was used to determine associations among continuous variables. Multivariate analysis was performed using stepwise forward logistic regression. All reported p values are two-tailed.
The level of significance was set at 5%. We calculated odds ratios (OR) and 95% confidence intervals (95% CI).
Results
Patients
We enrolled 173 patients in the study, 36 of which were excluded: chest X-ray was normal in 23, eight showed abnormalities without pneumonia, two were suspected of nosocomial pneumonia, and three had no respiratory specimen available.
The 137 included patients had a median age of 58 years (16 to 96), a male/female ratio of 1.4
and an ethnic distribution as follows: 77 Melanesian (56.2%), 23 European (16.8%), 23
Wallisian (16.8%), 4 Tahitian (2.9%), and 10 from other minor groups (7.3%).
There was no significant association between ethnic groups and any comorbid condition (table 1) , although some factors were observed more frequently in Wallisian patients: current cigarette smoker (60.9%), pulmonary disease (34.8%), and diabetes mellitus (26.1%).
Immunization rates against seasonal influenza and S.pneumoniae are summarized in figure 1.
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Twenty-four patients (17.5%) were treated with antibiotics (at least one beta-lactam) prior to hospitalization.
CAP patients main characteristics
Twenty-two patients (16.0%) were admitted to the ICU (table 1) . These patients, 17 male and 5 female, had a median age of 62 years (37-81). The rate of ICU admission did not differ significantly between ethnic or age groups. Fifty-one patients (37.2%) had a PSI < III, 36 of which (70.5%) were hospitalized for reasons other than pneumonia severity. Length of hospital stay ranged from 1 to 65 days, with a median of 8 days. Mortality rate was 5.8%
(8/137).
Microbiological investigations
Bacteriology
Only 59 of the 127 sputum samples collected (46.4%) were considered to be of good quality.
Blood culture was positive in 20 patients. In 4 cases, it was the only positive test; the others were also positive for at least another technique (S. pneumoniae urinary antigen test, n = 12; positive culture from a respiratory specimen, n = 6). Pleural fluid analysis detected one isolate of Staphylococcus aureus.
Urinary antigen detection was positive for S. pneumoniae in 40 of 133 patients (30%) and the diagnosis rate of pneumococcal CAP was increased by a factor of 2.1 using this test systematically; no urinary samples were tested positive for L. pneumophila serotype 1.
C. pneumoniae PCR assays were performed for 132 patients, yielding one positive result.
M. pneumoniae IgM were detected for 6 of 136 patients tested.
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Immunofluorescence assays were positive for five patients (influenza virus A, n = 4; PIV-3, n = 1). Paired sera were obtained for only 34 of 137 patients. For this small subset of patients, 22 were positive for ADV (n = 1), PIV-3 (n = 1), influenza virus A (n = 16), influenza virus A + RSV (n = 1) and possible persistent antibodies against influenza vaccine antigens (n = 3).
Diagnosis rates of the different techniques for influenza virus detection are shown in figure 2. of CAP (n = 18) while mixed bacterial and mixed viral infections accounted for 9.5% (n = 13) and 0% of CAP respectively (tables 3 and 4). aureus (3.5%).
CAP etiologies
The most frequent (n = 11) and significant coinfection was S. pneumoniae associated with influenza A virus (p = 0.004).
Of the eight patients who died, the causative agent was identified in five: Escherichia coli + K. pneumoniae, n = 1; K. pneumoniae, n = 2; S. pneumoniae, n = 1; S. pneumoniae + influenza virus A, n = 1. We noticed a particularly high incidence of Gram-negative enteric pasteur-00705151, version 1 -7 Jun 2012 bacilli bacteremia (K. pneumoniae = 3) in this group but there was no significant association with CAP severity (p = 0.067) or suspicion of aspiration pneumonia.
Epidemiological patterns
CAP due to S. pneumoniae (n = 48) occurred more frequently in patients aged < 45 years (p = 0.04), with no significant difference between ethnic groups. There was no significant association between ethnicity or comorbidity and etiology of CAP. S. pneumoniae was the most frequent pathogen isolated in patients admitted to ICU (9/22). However, its frequency in this subgroup was similar to that observed for the whole population studied (40.9% and 41.0% respectively). K. pneumoniae was the most frequent agent detected in fatal CAP, but the association between this bacterium and ICU admission was not significant (p = 0.067).
There was no relationship between viral-bacterial co-infections and ICU admission neither with a PSI > III. Incidence of CAP was significantly higher during southern winter (p = 0.007). This increased incidence was associated with epidemic seasonal influenza observed during the same period in the general population (p = 0.002; figure 4). Multivariate analysis only showed a significant association between influenza-associated CAP and southern winter (p = 0.03).
Discussion
This is the first study of CAP etiology in New Caledonia. Etiology was attributed in 59.8% of cases, similar to published data (Jennings et al. 2008) . S. pneumoniae urinary antigen testing provided a good alternative to tests involving more invasive means of sample collection.
Indeed, the increase in diagnosis rate was consistent with a previous study using further tests such as lung aspirate analysis after transthoracic needle aspiration (Ruiz-Gonzalez et al.
1999).
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Viruses In New Caledonia, despite differences in traditional medicine, way of life and socioeconomical criteria, we did not find any differences in CAP etiology or severity between ethnic groups. However, S. pneumoniae accounted for 41% of CAP in Melanesians under 45 years old but only 26% of Melanesian CAP patients over 45 years old. This difference is not pasteur-00705151, version 1 -7 Jun 2012 significant but it may be of interest to investigate age stratification in a larger study group. 
Analysis of S. pneumoniae
